- Home
- SHBI vs DAWN Comparison
SHBI vs DAWN Comparison
Compare SHBI & DAWN Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- SHBI
- DAWN
- Stock Information
- Founded
- SHBI 1876
- DAWN 2018
- Country
- SHBI United States
- DAWN United States
- Employees
- SHBI N/A
- DAWN N/A
- Industry
- SHBI Major Banks
- DAWN Biotechnology: Pharmaceutical Preparations
- Sector
- SHBI Finance
- DAWN Health Care
- Exchange
- SHBI Nasdaq
- DAWN Nasdaq
- Market Cap
- SHBI 532.0M
- DAWN 624.8M
- IPO Year
- SHBI N/A
- DAWN 2021
- Fundamental
- Price
- SHBI $16.79
- DAWN $7.20
- Analyst Decision
- SHBI Buy
- DAWN Strong Buy
- Analyst Count
- SHBI 1
- DAWN 7
- Target Price
- SHBI $20.00
- DAWN $27.86
- AVG Volume (30 Days)
- SHBI 123.0K
- DAWN 2.1M
- Earning Date
- SHBI 07-24-2025
- DAWN 08-05-2025
- Dividend Yield
- SHBI 3.03%
- DAWN N/A
- EPS Growth
- SHBI 169.45
- DAWN N/A
- EPS
- SHBI 1.61
- DAWN N/A
- Revenue
- SHBI $208,209,000.00
- DAWN $187,638,000.00
- Revenue This Year
- SHBI N/A
- DAWN $16.42
- Revenue Next Year
- SHBI $16.61
- DAWN $47.52
- P/E Ratio
- SHBI $9.84
- DAWN N/A
- Revenue Growth
- SHBI 24.24
- DAWN 2190.50
- 52 Week Low
- SHBI $11.47
- DAWN $5.64
- 52 Week High
- SHBI $17.61
- DAWN $16.76
- Technical
- Relative Strength Index (RSI)
- SHBI 64.59
- DAWN 62.39
- Support Level
- SHBI $15.80
- DAWN $6.71
- Resistance Level
- SHBI $16.09
- DAWN $7.12
- Average True Range (ATR)
- SHBI 0.39
- DAWN 0.32
- MACD
- SHBI 0.08
- DAWN 0.10
- Stochastic Oscillator
- SHBI 98.26
- DAWN 85.05
About SHBI Shore Bancshares Inc
Shore Bancshares Inc is a financial holding company. It offers personalized banking, insurance, and investment services to families and businesses in the Mid-Atlantic region. It operates in one business segment- banking. The company's primary source of revenue is derived from interest earned on commercial, residential mortgage and other loans, and fees charged in connection with lending and other banking services located in Maryland, Delaware and Virginia.
About DAWN Day One Biopharmaceuticals Inc.
Day One Biopharmaceuticals Inc is a clinical-stage biopharmaceutical company. It is dedicated towards developing and commercializing targeted therapies for patients of all ages with genetically defined cancers. Initially, it focuses on clinical development efforts on pediatric patients living with cancer, a vulnerable population that has been underserved in the recent revolution in targeted therapeutics and immuno-oncology. The product candidate, DAY101, is an oral, brain-penetrant, highly-selective type II pan-rapidly accelerated fibrosarcoma, or pan-RAF, and kinase inhibitor.